# EDGAR Filing Document

**Accession Number:** 0001620749
**File Stem:** 0001640334-26-000512
**Filing Date:** 2026-3
**Character Count:** 87780
**Document Hash:** 452276167911e00fb9aa1e7838c44efc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001640334-26-000512.hdr.sgml**: 20260323

**ACCESSION NUMBER**: 0001640334-26-000512

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 55

**CONFORMED PERIOD OF REPORT**: 20260131

**FILED AS OF DATE**: 20260323

**DATE AS OF CHANGE**: 20260323

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Panamera Holdings Corp
- **CENTRAL INDEX KEY:** 0001620749
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 465707326
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55569
- **FILM NUMBER:** 26781523

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 WEST LOOP SOUTH, SUITE 1820
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77056
- **BUSINESS PHONE:** 713-878-7200

**MAIL ADDRESS:**
- **STREET 1:** 2000 WEST LOOP SOUTH, SUITE 1820
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77056

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PANAMERA HEALTHCARE Corp
- **DATE OF NAME CHANGE:** 20140926

?xml version='1.0' encoding='ASCII'? pnht_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 10-Q**

(Mark One)

---

| | |
|:---|:---|
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|  | For the quarterly period ended **<u>January 31, 2026</u>** |
| or | or |
| ☐ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|  | For the transition period from __________ to __________ |

---

Commission File Number **<u>000-55569</u>**

---

| |
|:---|
| **PANAMERA HOLDINGS CORPORATION** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Nevada** | **46-5707326** |
| (State or other jurisdiction of<br>incorporation or organization) | (IRS Employer<br>Identification No.) |
| **2000 West Loop South, Suite 1820 Houston, Texas** | **77056** |
| (Address of principal executive offices) | (Zip Code) |

---

**<u>(713) 878-7200</u>**

(Registrant's telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act:do

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes&nbsp;&nbsp;&nbsp;&nbsp; ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes&nbsp;&nbsp;&nbsp;&nbsp; ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated Filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) ☐ Yes ☒ NO

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date 79,886,074 shares of common stock outstanding as of March 23, 2026.

**TABLE OF CONTENTS**

**[PART I - FINANCIAL INFORMATION](#p1)**

---

| | | |
|:---|:---|:---|
| [Item 1.](#i1) | [Financial Statements](#i1) | 3 |
| [Item 2.](#i2) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i2) | 17 |
| [Item 3.](#i3) | [Quantitative and Qualitative Disclosures About Market Risk](#i3) | 22 |
| [Item 4.](#i4) | [Controls and Procedures](#i4) | 22 |

---

**[PART II - OTHER INFORMATION](#p2)**

---

| | | |
|:---|:---|:---|
| [Item 1.](#p2i1) | [Legal Proceedings](#p2i1) | 23 |
| [Item 1A.](#p2i1a) | [Risk Factors](#p2i1a) | 23 |
| [Item 2.](#p2i2) | [Unregistered Sales of Equity Securities and Use of Proceeds](#p2i2) | 23 |
| [Item 3.](#p2i3) | [Defaults Upon Senior Securities](#p2i3) | 23 |
| [Item 4.](#p2i4) | [Mine Safety Disclosures](#p2i4) | 23 |
| [Item 5.](#p2i5) | [Other Information](#p2i5) | 23 |
| [Item 6.](#p2i6) | [Exhibits](#p2i6) | 24 |
| [SIGNATURES](#sig) | [SIGNATURES](#sig) | 25 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#toc)* |

---

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**PANAMERA HOLDINGS CORPORATION**

**Consolidated Balance Sheets**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **January 31,**<br>**2026** | **July 31,**<br>**2025** |
| **Assets** |  |  |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | $17061 | $85980 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 7151 | 6901 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable  | 57043 | 2543 |
| Total Current Assets | 81255 | 95424 |
| Non-Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposit for rent  |  | 4000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposit for license  |  | 639645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use asset | 43638 | 64450 |
| **Total Assets** | $124893 | $803519 |
| **Liabilities and Stockholders' Equity** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $292225 | $91206 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short term advance payable  | 11653 | 11653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to related party |  | 7111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Note payable, related party  | 3904855 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liability - current portion | 46734 | 45385 |
| Total Current Liabilities | 4255467 | 155355 |
| Non-current Liability: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liability | - | 23709 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 4255467 | 179064 |
| Stockholders' Equity (Deficit) |  |  |
| Preferred stock: 50,000,000 authorized; $0.0001 par value, no shares issued and outstanding |  |  |
| Common stock: 550,000,000 authorized; $0.0001 par value, 79,886,074 shares and 52,735,000 shares issued at January 31, 2026, and July 31, 2025, respectively | 7989 | 5274 |
| Additional paid in capital | 172956331 | 23823900 |
| Treasury stock, at cost: 6,000,000 shares at January 31, 2026, and July 31, 2025, respectively | (600) | (600) |
| Common stock to be issued,0 shares and 50,000 shares at January 31, 2026, and July 31, 2025, respectively |  | 100000 |
| Accumulated deficit  | (177094294) | (23304119) |
| Total Stockholders' Equity (Deficit) | (4130574) | 624455 |
| **Total Liabilities and Stockholders' Equity (Deficit)** | $124893 | $803519 |

---

*The accompanying notes to the unaudited financial statements are an integral part of these statements.*

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#toc)* |

---

**PANAMERA HOLDINGS CORPORATION**

**Consolidated Statements of Operations**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the**  | **For the**  | **For the** | **For the** |
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **January 31,** | **January 31,** | **January 31,** | **January 31,** |
|  | **2026** | **2025** | **2026** | **2025** |
| Revenues - related party | $- | $39231 | $- | $74894 |
| Revenues | 139500 | - | 139500 | 7905 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 139500 | 39231 | 139500 | 82799 |
| Cost of revenues - related party |  | 20750 |  | 20750 |
| Cost of revenues | 54900 | - | 54900 | 18493 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of revenue | 54900 | 20750 | 54900 | 39243 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Gross profit**  | 84600 | 18481 | 84600 | 43556 |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 36785 | 26508 | 69423 | 26652 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses |  |  | 153400000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administration expenses | 126456 | 90078 | 309276 | 204153 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 163241 | 116586 | 153778699 | 230805 |
| **Net loss from operations** | (78641) | (98105) | (153694099) | (187249) |
| **Other income (expense)** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 110 | 61 | 1740 | 81 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (48068) | (1971) | (97816) | (3908) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (47958) | (1910) | (96076) | (3827) |
| **Loss from operations before taxes** | (126599) | (100015) | (153790175) | (191076) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit | - | - | - | - |
| **Loss from operations**  | $**(126599)** | $**(100015)** | $**(153790175)** | $**(191076)** |
| **Net Loss** | $**(126599)** | $**(100015)** | $**(153790175)** | $**(191076)** |
| **Net loss per common share - basic and diluted** | $(0.00) | $(0.00) | $(2.08) | $(0.00) |
| **Weighted average number of common shares outstanding, basic and diluted** | 73896490 | 45519341 | 73891269 | 45468926 |

---

*The accompanying notes to the unaudited financial statements are an integral part of these statements.*

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#toc)* |

---

**PANAMERA HOLDINGS CORPORATION**

**Consolidated Statements of Changes in Stockholders' Deficit**

**(Unaudited)**

***For the Three and Six Months Ended January 31, 2026***

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  | |  |  | **Common Stock**  | **Common Stock**  | | |
|  | **Common Stock** | **Common Stock** | | **Treasury Stock** | **Treasury Stock** | **to be issued**  | **to be issued**  | | |
|  | **Shares**  | **Amount**  | **Additional**<br>**Paid in** <br> **Capital**  | **Shares**  | **Amount**  | **Shares**  | **Amount**  | <br>**Accumulated**<br> **Deficit**  | <br><br> **Total**  |
| **Balance - July 31, 2025** | 52735000 | $5274 | $23823900 | (6000000) | $(600) | 50000 | $100000 | $(23304119) | $624455 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance common stock for subscription | 50000 | 5 | 99995 |  |  | (50000) | (100000) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance common stock for cash | 91074 | 9 | 499991 |  |  |  |  |  | 500000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock subscriptions for common stock  |  |  |  |  |  | 10000 | 35000 |  | 35000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Imputed interest on related party loans  |  |  | 146 |  |  |  |  |  | 146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted common stock for license acquisition  | 27000000 | 2700 | 148497300 |  |  |  |  |  | 148500000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss for the period | - | - | - | - | - | - | - | (153663576) | (153663576) |
| **Balance - October 31, 2025** | 79876074 | 7988 | 172921332 | (6000000) | (600) | 10000 | 35000 | (176967695) | (4003975) |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance common stock for subscription  | 10000 | 1 | 34999 |  |  | (10000) | (35000) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss for the period |  |  |  |  |  |  |  | (126599) | (126599) |
| **Balance - January 31, 2026** | 79886074 | $7989 | $172956331 | (6000000) | $(600) | - | $- | $(177094294) | $(4130574) |

---

***For the Three and Six Months Ended January 31, 2025***

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | **Treasury Stock** | **Treasury Stock** | | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid in**<br> **Capital** | **Shares** | **Amount** |<br>**Accumulated**<br> **Deficit** |<br> **Total** |
| **Balance - at July 31, 2024** | 51410000 | $5141 | $22581051 | (6000000) | $(600) | $(22767705) | $(182113) |
| &nbsp;&nbsp;&nbsp;&nbsp;Imputed interest on related party loan |  |  | 1878 |  |  |  | 1878 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted stock-based compensation |  |  | 6944 |  |  |  | 6944 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock option compensation |  |  | 6538 |  |  |  | 6538 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss for the period | - | - | - | - | - | (91061) | (91061) |
| **Balance - at October 31, 2024** | 51410000 | $5141 | $22596411 | (6000000) | $(600) | $(22858766) | $257814) |
| &nbsp;&nbsp;&nbsp;&nbsp;Imputed interest on related party loan |  |  | 1884 |  |  |  | 1884 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance common stock for cash | 100000 | 10 | 49990 |  |  |  | 50000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss for the period | - | - | - | - | - | (100015) | (100015) |
| **Balance - at January 31, 2025** | 51510000 | $5151 | $22648285 | (6000000) | $(600) | $(22958781) | $(305945) |

---

 *The accompanying notes to the unaudited financial statements are an integral part of these statements.*

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#toc)* |

---

**PANAMERA HOLDINGS CORPORATION**

**Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the**  | **For the**  |
|  | **Six Months Ended** | **Six Months Ended** |
|  | **January 31,** | **January 31,** |
|  | **2026** | **2025** |
| **Cash Flows from Operating Activities:**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(153790175) | $(191076) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Imputed interest on related party loan | 146 | 3762 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 153400000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  | 13482 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expenses | 20812 | 19539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 201019 | 130718 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable-related party |  | 1650 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (54500) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 3750 | (596) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other receivable |  | (1679) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (22360) | (17087) |
| Net Cash Used in Operating Activities | (241308) | (41287) |
| **Cash Flows from Financing Activities:**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment related party loans | (7111) | (10000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment note payable - related party | (355500) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from common stock issuance | 535000 | 50000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Cash Provided by Financing Activities | 172389 | 40000 |
| Net change in cash | (68919) | (1287) |
| Cash, beginning of period | 85980 | 1838 |
| Cash, end of period | $17061 | $551 |
| Supplemental cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $- | $59 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for taxes | $- | $- |
| Supplemental disclosure of non-cash financing |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassified cash deposits for license to note payable - related party | $639645 | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance common stock for subscription | $100000 | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Related party debt issued for payment of accounts payable | $- | $11398 |

---

*The accompanying notes to the unaudited financial statements are an integral part of these statements.*

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#toc)* |

---

**PANAMERA HOLDINGS CORPORATION**

**Notes to the Unaudited Interim Consolidated Financial Statements**

**January 31, 2026**

**NOTE 1 – ORGANIZATION, DESCRIPTION OF BUSINESS**

Panamera Holdings Corporation (the "Company") is a Nevada corporation incorporated on May 20, 2014. It is based in Houston, TX. Effective October 21, 2021, the Company changed its name from Panamera Healthcare Corporation to Panamera Holdings Corporation and increased the number of authorized shares of common stock from 150,000,000 shares of common stock to 550,000,000 shares of common stock, par value $0.0001 per share. The Company's fiscal year end is July 31.

The Company are currently seeking new business opportunities with established operating business entities to merge with or to acquire with our primary emphasis in the environmental services industry, emerging innovative technologies led by innovation with integration. The Company's activities have been limited to its formation and specializing in metals recycling, domestically sourced critical earth materials from recycling CO₂, and energy production.

On August 1, 2025, the Company entered into a license agreement with Rain Cage Carbon, Inc. ("Ranin Cage") for securing exclusive rights to the innovative systems of Rain Cage for use in the U.S and Mexico, including groundbreaking carbon conversion and clean energy technologies. This will enhance abilities to raise equity capital and specializing in metals recycling, domestically sourced critical earth materials from recycling CO₂, and energy production.

On June 2, 2023, The Company's Board of Directors approved the creation of three wholly owned subsidiaries, named Panamera Metals Corporation, Panamera Technologies Corporation and Panamera Waste Corporation. On July 20, 2023, the three wholly owned subsidiaries were registered in the State of Texas.

**NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Basis of Presentation***

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company's Annual Report on Form 10-K, for the year ended July 31, 2025, as filed with the SEC on November 25, 2025.

***Basis of Consolidation***

The consolidated financial statements include the accounts of Panamera Holdings Corporation and its wholly owned subsidiaries Panamera Metals Corporation, Panamera Technologies Corporation and Panamera Waste Corporation, collectively referred to as the "Company". All inter-company balances and transactions are eliminated in consolidation.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#toc)* |

---

***Use of Estimates***

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.

***Accounts Receivable***

Accounts receivables are recorded in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) 310, *"Receivables."* Accounts receivables are recorded at the invoiced amount or agreement and do not bear interest. The Company does not currently have any amount recorded as an allowance for doubtful accounts. Based on the management's estimate and based on all accounts being current, the Company has not deemed it necessary to reserve for doubtful accounts at this time.

***Revenue Recognition***

The Company recognizes revenue from its contracts with customers in accordance with *ASC 606 – Revenue from Contracts with Customers.* The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

Revenue related to contracts with customers is evaluated utilizing the following steps:

(i) Identify the contract, or contracts, with a customer;

(ii) Identify the performance obligations in the contract;

(iii) Determine the transaction price;

(iv) Allocate the transaction price to the performance obligations in the contract;

(v) Recognize revenue when the Company satisfies a performance obligation.

When the Company enters into a contract, the Company analyses the services required in the contract in order to identify the required performance obligations which would indicate the Company has met and fulfilled its obligations. For the current contracts in place, the Company has identified performance obligations as one single event, the sign-off by both parties that current objectives have been achieved. To appropriately identify the performance obligations, the Company considers all of the services required to be satisfied per the contract, whether explicitly stated or implicitly implied. The Company allocates the full transaction price to the single performance obligation being satisfied. The company recognizes the revenue of steel raw material at a point in time, that is which the risks and rewards of ownership of the material transfer from the Company to the customer by issuance invoice according to agreement

***Net Loss Per Share of Common Stock***

The Company has adopted ASC Topic 260, "Earnings per Share," ("EPS") which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying consolidated financial statements, basic earnings (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.

For the six months ended January 31, 2026 and 2025, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** |
|  | **January 31** | **January 31** |
|  | **2026** | **2025** |
|  | **Shares** | **Shares** |
| Convertible Debt-related parties |  | 65893 |
| Short term advance payable  | 11653 | 11653 |
| Unvested common stock option  | 12498 | 12498 |
| Note payable - related party | 12607 | - |
|  | 36758 | 90044 |

---

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#toc)* |

---

***Recent Accounting Pronouncements***

The Company has implemented all the new pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial statements or results of operations.

***Concentrations of Credit Risk***

The Company's consolidated financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company's management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

***Financial Instruments and Fair Value Measurements***

The Company follows ASC 820, "Fair Value Measurements and Disclosures," on fair value measurements for financial instruments measured on a recurring basis, as well as for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price, or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs to value its financial instruments:

● Level 1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.

● Level 2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.

● Level 3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires a significant judgment or estimation.

***Recent Accounting Pronouncements***

The Company has implemented all new pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial statements or results of operations.

In November 2023, the FASB issued Accounting Standards Update ("ASU") No. 2023-07, "S*egment Reporting (Topic 280): Improvements to Reportable Segment Disclosure.*" The ASU updated reportable segment disclosure requirements, primarily through requiring enhanced disclosures about significant segment expenses and information used to assess segment performance. ASU 2023-07 is effective for the Company for fiscal years beginning after December 15, 2024. The Company adopted ASU No. 2023-07 during the period ended January 31, 2026. The pronouncement had no material impact on the Company's financials.

***Segment Information***

Our Chief Executive Officer ("CEO") is the chief operating decision maker who reviews consolidated financial information for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reporting segment.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#toc)* |

---

Our CEO assesses performance and decides how to allocate resources primarily based on net income, which is reported on our Consolidated Statements of Operations. Total assets on the Balance Sheets represent our segment assets. Total revenue and net loss represent our results of operations.

***Commitments and Contingencies***

The Company follows ASC 450-20, "Loss Contingencies," to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred, and the amount of the assessment can be reasonably estimated.

***Share-Based Compensation***

ASC 718 "*Compensation - Stock Compensation*" prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The Company has adopted the guidance included under ASU 2018-07, stock-based compensation issued to non-employees and consultants. Equity-based payments to non-employees are measured at grant-date fair value of the equity instruments that the Company is obligated to issue when the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied. Equity-classified non-employee share-based payment awards are measured at the grant date.

**License Technology**

The cost of an asset acquisition, including transaction costs, is allocated to identifiable assets acquired and liabilities assumed based on a relative fair value basis. Goodwill is not recognized as an asset acquisition. Any difference between the cost of an asset acquisition and the fair value of the net assets acquired is allocated to the non-monetary identifiable assets based on their relative fair values. Assets acquired as part of an asset acquisition that are considered to be in-process research and development (IPR&D) are immediately expensed unless there is an alternative future use in other research and development projects.

***Leases***

ASC 842 supersedes the lease requirements in ASC 840 "Leases" and generally requires lessees to recognize operating and finance lease liabilities and corresponding right-of-use ("ROU") assets on the balance sheet and to provide enhanced disclosures surrounding the amount, timing and uncertainty of cash flows arising from leasing arrangements.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.

Any lease with a term of 12 months or less is considered short-term. As permitted by ASC 842, short-term leases are excluded from the ROU assets and lease liabilities on the consolidated balance sheets. Consistent with all other operating leases, short-term lease expense is recorded on a straight-line basis over the lease term.

The Company determines the present value of minimum future lease payments for operating leases by estimating a rate of interest that it would have to pay to borrow on a collateralized basis over a similar term, an amount equal to the lease payments and a similar economic environment (the "incremental borrowing rate" or "IBR").The Company determines the appropriate IBR by identifying a reference rate and making adjustments that take into consideration financing options and certain lease-specific circumstances.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#toc)* |

---

**NOTE 3 - GOING CONCERN**

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of January 31, 2026, the Company has a loss of $153,790,175, an accumulated deficit of $177,094,294. The Company intends to fund operations through debt and/or equity financing arrangements and related party advances, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the year ending July 31, 2026.

The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.

These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**NOTE 4 – ACQUISITION OF LICENSED TECHNOLOGY**

On August 1, 2025, the Company entered into a Head License Agreement "Agreement" with an entity" Target" for acquisition a license to certain technologies of Target's innovation systems for use along pursuing strategic partnership and merger of the Company and Target. The Company will have a license to Target's system technology for carbon conversion to fullerenes and nanotubes. The consideration license fees agreed (i) one - time up-front payment of $4,900,000, (ii) ongoing license fee of 25% of the net income generated from license's activities (iii) grant of 27,000,000 shares of restricted common stock of the Company. The Company and Target entered into a promissory note agreement for payment of up-front license fee of $4,900,000, with initial payment of $500,000 and quarterly payment balance starting October 1, 2025, for period of 18 months and interest bearing of 4.9% per annum.

During the year ended July 31, 2025, the Company made deposits of $639,645 in contraction of license acquisition agreement.

On August 1, 2025, the Company issued 27,000,000 shares of restricted common stock in connection with the executed license acquisition.

The Company recognized the fair value of license agreement with consideration of value of 27,000,000 shares of restricted common stock for amount of $148,500,000 issued on August 1, 2025 and face value of $4,900,000 note payable for an aggregate amount of $153,400,000.

The transaction was accounted for as an asset acquisition of in process research & development (IPR&D) with no alternative future use. The Company recognized the entire amount of the consideration of $153,400,000 as research and development expenses upon closing the transaction.

**NOTE 5 – PROMISSORY NOTE -RELATED PARTY**

Pursuant to license agreement dated August 1, 2025 (Note 4), the Company entered into a promissory note agreement for payment of up-front license fee of $4,900,000, with initial payment of $500,000 and quarterly payment balance starting October 1, 2025, for period of 18 months and interest bearing of 4.9% per annum.

During the six months ended January 31, 2026 and the year ended July 31, 2025, the Company repaid due of $355,500 and $639,645, respectively. During the six months ended January 31, 2026, the Company recognized interest expenses of $97,670.

As of January 31, 2026, the Company has promissory note payable of $3,904,855 and accrued interest of $97,670.

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#toc)* |

---

**NOTE 6 - RELATED PARTY TRANSACTIONS**

On June 13, 2024, the Company entered into an employment agreement with Juan Juarez for the position of Senior Vice President of Finance with an annual salary of $100,000. Mr. Juarez will receive 125,000 shares of restricted common stock of Panamera Holdings Corporation having a 3-year vesting period, he will be entitled to 50,000 three -year stock options at $1.50 per share vesting fully in the first year on a monthly basis. During the six months ended January 31, 2025, the Company recognized salary of $15,000. paid salary of $16,827 and stock -based compensation of $13,482. Mr. Jaurez resigned on September 24, 2024.

During the six months ended January 31, 2026, and 2025 related parties financed $0 and $11,398 for operation expenses and repaid related parties' loan of $7,111 and $10,000, respectively.

During the six months ended January 31, 2026, and 2025, the Company recognized $146 and $3,762 interest on related party balances and imputed in additional paid-in-capital, respectively

During the six months ended January 31, 2025, and 2025, the Company generated revenues of $0 and $74,894 from sales of material to a company controlled by a related party.

During the six months ended January 31, 2026 and 2025, the Company incurred cost of revenues of $0 and $20,750 from services rendered by a subcontractor controlled by a related party.

During the six months ended January 31, 2026, and 2025, the Company recognized salary of $100,000 and $100,000 and paid salary of $75,000 and $78,500 to the Company's president.

During the six months ended January 31, 2026, and 2025, the Company recognized and paid $78,200 and $0 management fees to the Company's Chief Executive Officer, respectively.

During the six months ended January 31, 2026 and 2025, the Company recolonized salary of $24,000 and $0 and paid salary of $20,000 and $0 to the Company's Chief Financial Officer, respectively.

As of January 31, 2026, and July 31, 2025, the Company was obliged for unsecure, non-interest-bearing demand loans to one related party, with balances of $0 and $7,111 respectively.

Pursuant to terms and condition license agreement dated August 1, 2025 (Note 4), the Company entered into a promissory note agreement of $4,900,000 with Licensor (Noteholder) for period of 18 months and interest bearing of 4.9% per annum. On August 1, 2025, the Company issued 27,000,000 shares of restricted common stock in connection with the executed license acquisition to Licensor (Noteholder), valued at $148,500,000. By issuance of the shares, the Noteholder became related party. During the six months ended January 31, 2026, the Company repaid due of $355,500 and recognized interest expenses of $97,670.

As of January 31, 2026, and July 31, 2025, the Company was obliged for unsecure, non-interest-bearing demand loans to a related party, with balances of $0 and $7,111 respectively. On June 2, 2023, the Company's Board of Directors approved and authorized any debt holder in the Company to voluntarily convert their debt into Controlled and Restricted shares of common stock at a conversion price of $1.00 per share within a 5-day period following receipt of notice from the Company in either electronic, verbal, or written form.

**Note 7 – LEASE**

On July 1, 2024, the Company entered into an operating lease for the office, with the term of 31 months, monthly lease expenses of $4,000 with condition the first two months free rent.

For the three and six months ended January 31, 2026, and 2025, right-of-use asset and lease information about the Company's operating lease consist of:

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#toc)* |

---

The components of lease expense were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended**  | **Six Months Ended**  |
|  | **January 31,** | **January 31,** | **January 31,** | **January 31,** |
|  | **2026** | **2025** | **2026** | **2025** |
| Operating lease cost | $12000 | $12000 | $24000 | $20000 |
| Variable lease cost  | (774) | (774) | (1548) | 2452 |
| Total lease cost | $11226 | $11226 | $22452 | $22452 |

---

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended**  | **Six Months Ended**  |
|  | **January 31,**  | **January 31,**  |
|  | **2026** | **2025** |
| Cash paid for operating cash flows from operating leases  | $24000 | $20000 |
| Weighted-average discount rate — operating leases | 5.88% | 5.88% |
| Weighted-average remaining lease term - operating leases (year) | 1.00 | 2.00 |

---

Supplemental balance sheet information related to leases consists of:

---

| | | |
|:---|:---|:---|
|  | **January 31,**<br>**2026** | **July 31,**<br>**2025** |
| Operating lease right-of-use asset  | $43638 | $64450 |
| Operating lease liabilities: |  |  |
| Current portion | 46734 | $45385 |
| Non-current portion  | - | 23709 |
|  | $46734 | $69094 |

---

The following table outlines the maturities of our lease liabilities as of January 31, 2026:

---

| | |
|:---|:---|
| Year ending Jul 31, |  |
| 2026 (excluding the six months ended January 31, 2026) | $24000 |
| 2027 | 24000 |
| Thereafter | - |
|  | $48000 |
| Less imputed interest  | (1266) |
| Operating lease liabilities | $46734 |

---

**NOTE 8 - STOCKHOLDERS' EQUITY** 

***Preferred Stock***

The Company has authorized 50,000,000 shares of preferred stock with a par value of $0.0001 per share. No preferred stock was issued or outstanding as of January 31, 2026, and July 31, 2025.

***Common Stock***

The Company has authorized 550,000,000 shares of common stock with a par value of $0.0001 per share.

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#toc)* |

---

On June 17, 2024, the Company entered into an engagement agreement with a director and granted 125,000 shares of restricted common stock, with term of three years, fully vesting over a three-year period on a monthly basis. The Company valued the restricted common stock in amount of $124,988 at market price on grant date. During the six months ended January 31, 2025, the Company recognized stock-based compensation of $6,944. On September 24, 2024, the employee resigned.

During six months ended January 31, 2025, the Company issued 100,000 shares of restricted common stock at price of $0.50 per share for an amount of $50,000 in cash.

During the six months ended January 31, 2026, the Company issued 101,074 shares of restricted common stock at price of $3.50 - $5.49 per share for an amount of $535,000 in cash.

During the six months ended January 31, 2026, the Company issued 50,000 shares of restricted common stock at price of $2.00 per share to settle the stock subscription payable of $100,000.

During the six months ended January 31, 2026, the Company issued 27,000,000 shares of restricted common stock in connection with the executed license acquisition, valued at $148,500,000 (Note 4).

As of January 31, 2026, and July 31, 2025, there were 79,886,074 shares and 52,735,000 shares of common stock issued and 73,886,074 shares and 46,735,000 shares of common stock outstanding, respectively.

***Treasury Stock***

The Company records treasury stock at cost. Treasury stock is comprised of shares of common stock purchased by the Company at par value. As of January 31, 2026, and July 31, 2025, the Company had 6,000,000 shares of treasury stock valued at $600, respectively.

***Stock Option***

On June 17, 2024, the Company entered into an engagement agreement with an officer and granted stock option of 50,000 shares of common stock, valued at $39,225 with term of three years, exercise price of $1.50 per share, fully vesting in the first year on a monthly basis. On September 24, 2024, an officer resigned from his position. During the six months ended January 31, 2025, the Company recognized stock option expense of $6,538.

The following is a summary of the change in stock option during the six months ended January 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
|  | **Options Outstanding** | **Options Outstanding** | |
|  | **Number of**<br>**Options** | **Weighted**<br>**Average**<br>**Exercise**<br>**Price** | **Weighted**<br>**Average**<br>**Remaining**<br>**life**<br>**(years)** |
| Outstanding, July 31, 2025 | 12498 | $1.50 | 2.13 |
| Granted |  |  |  |
| Exercised |  |  |  |
| Forfeited/canceled | - | - | - |
| Outstanding, January 31, 2026 | 12498 | $1.50 | 1.38 |
| Exercisable options, January 31, 2026 | 12498 | $1.50 | 1.38 |

---

The intrinsic value of the options as of January 31, 2026, is $65,490.

The Company determined the stock option to be an equity instrument, to be valued as a level 3 fair value financial instrument valued on a non-recurring basis and utilized the Black-Scholes valuation model.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#toc)* |

---

The Black-Scholes model, which requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The current stock price is based on historical issuances. Expected volatility is based on the historical stock price volatility of the Company's common stock. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods. Expected term is calculated using a simplified method for plain vanilla options.

The Company utilized the following assumptions on grant date of June 17, 2024:

---

| | |
|:---|:---|
| Expected term | 2 years |
| Expected average volatility | 187% |
| Expected dividend yield |  |
| Risk-free interest rate | 4.75% |

---

**NOTE 9 – CONCENTRATION**

As of January 31, 2026, and July 31, 2025 and for six months ended January 31, 2026, and 2025, customer and supplier concentrations (more than 10%) were as follows:

***Revenue and accounts receivable***

*Revenue*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Percentage of Revenue** | **Percentage of Revenue** | **Percentage of**  | **Percentage of**  |
|  | **Six Months Ended**  | **Six Months Ended**  | **Accounts Receivable**  | **Accounts Receivable**  |
|  | **January 31** | **January 31** | **January 31** | **July 31** |
|  | **2026** | **2025** | **2026** | **2025** |
| Customer A - related party |  | 90.45% |  |  |
| Customer B | 100.00% |  | 95.54% |  |
| Customer C | - | 3.54% | 4.46% | 100.00% |
| Total (as a group)  | 100.00% | 93.99% | 100.00% | 100.00% |

---

*Cost of Revenue*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Percentage of Purchase** | **Percentage of Purchase** | **Percentage of**  | **Percentage of**  |
|  | **Six Months Ended**  | **Six Months Ended**  | **Accounts Payable for Purchase**  | **Accounts Payable for Purchase**  |
|  | **January 31** | **January 31** | **January 31** | **July 31** |
|  | **2026** | **2025** | **2026** | **2025** |
| Supplier A - related party |  | 52.88% |  | -% |
| Supplier B  |  |  | 9.93% | 100.00% |
| Supplier C |  | 47.12% |  |  |
| Supplier D | 100.00% | - | 90.07% | - |
| Total (as a group)  | 100.00% | 100.00% | 100.00 | 100.00% |

---

**NOTE 10 – COMMITMENTS AND CONTINGENCIES**

From time to time the Company may become a party to litigation matters involving claims against the Company.

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#toc)* |

---

We are aware that Jeffrey Kilgore filed a lawsuit on August 28, 2025, in Jefferson County, Texas. *Cause No. 25DCCV1693, Jefferson County, Texas; Jeff Kilgore vs. Panamera Holdings Corporation*; the Plaintiff is claiming he is owed certain shares in compensation for services. This claim is disputed and without merit. Kilgore has requested a temporary injunction, and the hearing for same was set for January 22, 2026, then after it was postponed with new date to be set later. At this point an estimate for possible range of loss cannot be made. The company believes this is without merit, and we intend to vigorously defend against it.

**NOTE 11 – SUBSEQUENT EVENTS**

Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation unless noted below, no material events have occurred that require disclosure.

---

| |
|:---|
| 16 |
| *[**Table of Contents**](#toc)* |

---

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**FORWARD-LOOKING STATEMENTS**

This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Our unaudited financial statements are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report.

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to "common shares" refer to the common shares in our capital stock.

As used in this quarterly report, the terms "we", "us", "our" and "our Company" mean Panamera Holdings Corporation, unless otherwise indicated.

**General Overview**

We were incorporated under the laws of the State of Nevada on May 20, 2014. Effective October 21, 2021, the Company changed its name from Panamera Healthcare Corporation to Panamera Holdings Corporation and increased the number of authorized shares from 200,000,000 shares to 600,000,000 shares, par value $0.0001per share, of which 550,000,000 were common stock and 50,000,000 preferred stock.

Prior management intended to offer management and consulting services to healthcare organizations, but current management have redirected our efforts now to pursuing business opportunities including but not limited to the environmental services industry, emerging innovative technologies. To date, the Company's activities have been limited to its formation and the raising of equity capital and providing consulting services and activities in the scrap metal business.

**Our Current Business**

We are currently seeking new business opportunities with established operating business entities to merge with or to acquire with our primary emphasis in the environmental services industry, emerging innovative technologies led by innovation with integration. In certain instances, a target business may wish to become our subsidiary or may wish to contribute assets to us rather than merge with us. On August 1, 2025, we entered into an agreement with Rain Cage Carbon, Inc. to provide carbon capture capabilities to coal and other types of energy plants. This will enhance abilities to raise equity capital and specializing in metals recycling, domestically sourced critical earth materials from recycling CO₂, and energy production.

Any new acquisition or business opportunities that we may acquire will require additional financing. There can be no assurance, however, that we will be able to acquire the financing necessary to enable us to pursue our plan of operation. If our Company requires additional financing and we are unable to acquire such funds, our business may fail.

Our address is 2000 West Loop South, Suite 1820 Houston, Texas telephone number is (713) 878-7200.

---

| |
|:---|
| 17 |
| *[**Table of Contents**](#toc)* |

---

We have not ever declared bankruptcy, been in receivership, or involved in any kind of legal proceeding.

The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this annual report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include but are not limited to those discussed below and elsewhere in this report. Our unaudited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

**Plan of Operations and Cash Requirements**

We are no longer attempting to implement our original business plan. We now intend to look for other business opportunities to implement and/or operating companies with which to engage in a business combination including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration. Our focus will be on achieving long-term growth potential.

The analysis of new business opportunities will be undertaken by or under the supervision of the Company's management. While the Company has limited assets and minimal operating revenues, the Company has unrestricted flexibility in seeking, analyzing and participating in potential business opportunities and/or combinations in in any type of business, industry or geographical location. In its efforts, the Company will consider the following kinds of factors:

(a) potential for growth, indicated by new technology, anticipated market expansion or new products.

(b) competitive position as compared to other operations of similar size and experience within the industry segment as well as within the industry as a whole.

(c) strength and diversity of management, either in place or scheduled for recruitment.

(d) capital requirements and anticipated availability of required funds, to be provided by the Company or from operations, through the sale of additional securities, through joint ventures or similar arrangements or from other sources.

(e) the cost of participation by the Company as compared to the perceived tangible and intangible values and potentials.

(f) the extent to which the business opportunity can be advanced; and

(g) the accessibility of required management expertise, personnel, raw materials, services, professional assistance and other required items.

In applying the foregoing criteria, not one of which will be controlling, management will attempt to analyze all factors and circumstances and make a determination based upon reasonable investigative measures and available data. Potentially available opportunities may occur in many different industries, and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. Due to the Registrant's limited capital available for investigation, the Registrant may not discover or adequately evaluate adverse facts about the opportunity to be acquired. In addition, we will be competing against other entities that possess greater financial, technical and managerial capabilities for identifying and completing the implementation of any opportunities and/or business combinations.

---

| |
|:---|
| 18 |
| *[**Table of Contents**](#toc)* |

---

**Results of Operations**

The following summary of our results of operations should be read in conjunction with our unaudited consolidated financial statements for the period ended January 31, 2026, which are included herein.

Our operating results for the six months ended January 31, 2026, and 2025 and the changes between those periods for the respective items are summarized as follows.

*Results of Operations for the three months ended January 31, 2026, and 2025*

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | |
|  | **January 31,** | **January 31,** | |
|  | **2026** | **2025** | <br><br>**Changes**  |
| Revenues  | $139500 | $39231 | $100269 |
| Cost of revenues  | 54900 | 20750 | 34150 |
| Operating expenses | 163241 | 116586 | 46655 |
| Other expenses | 47958 | 1910 | 46048 |
| Net loss from operations  | $126599 | $100015 | $26584 |

---

During the three months ended January 31, 2026, and 2025, we generated $139,500 and $39,231 revenues related to sales of raw materials, respectively. During the three months ended January 31, 2026, and 2025, the revenues consist of $0 and $39,231 sales of raw material to a company controlled by a related party, respectively.

During the three months ended January 31, 2026, and 2025, the cost of revenues was $54,900 and $20,750 related to raw material, handling and transportation, respectively. During the three months ended January 31, 2026, and 2025, the cost of revenues consists of $0 and $20,750 related to purchase of raw material from a company controlled by a related party, respectively.

Operating expenses for the three months ended January 31, 2026, and 2025 were $163,241 and $116,586, respectively. For the three months ended January 31, 2026, and 2025, the operating expenses were primarily attributed to professional fees for maintaining reporting status with the Securities and Exchange Commission ("SEC") of $36,785 and $26,508 and general and administrative expenses of $126,456 and $90,078, respectively.

Other expenses for the three months ended January 31, 2026, and 2025, represent primarily interest expenses of $0 and $1,884 to our related parties, on funds advanced to the Company, interest expenses of $48,068 and $0 in connection with note payable, other interest expenses of $0 and $87 and interest income of $110 and $61, respectively.

*Results of Operations for the six months ended January 31, 2026, and 2025*

---

| | | | |
|:---|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** | |
|  | **January 31,** | **January 31,** | |
|  | **2026** | **2025** | <br><br>**Changes**  |
| Revenues  | $139500 | $82799 | $56701 |
| Cost of revenues | 54900 | 39243 | 15657 |
| Operating expenses | 153778699 | 230805 | 153547894 |
| Other expenses | 96076 | 3827 | 92249 |
| Net loss  | $153790175 | $191076 | $153599099 |

---

During the six months ended January 31, 2026, and 2025, we generated $139,500 and 82,799 revenues related to sales of raw materials, respectively. During the six months ended January 31, 2026, and 2025, the revenues consist of $0 and $74,894 sales of raw material to a company controlled by a related party, respectively.

---

| |
|:---|
| 19 |
| *[**Table of Contents**](#toc)* |

---

During the six months ended January 31, 2026, and 2025, the cost of revenues was $54,900 and $39,243 related to raw material, handling and transportation, respectively. During the six months ended January 31, 2026, and 2025, the cost of revenues consists of $0 and $20,750 related to purchase of raw material from a company controlled by a related party, respectively.

Operating expenses for the six months ended January 31, 2026, and 2025 were $153,778,699 and $230,805, respectively. For the six months ended January 31, 2026, and 2025, the operating expenses were primarily attributed to research and development expenses of $153,400,000 and $0, professional fees for maintaining reporting status with the Securities and Exchange Commission ("SEC") of $69,423 and $26,652 and general and administrative expenses of $309,276 and $204,153, respectively.

Pursuant to acquisition of licensed technology agreement dated August 1, 2025, the Company accounted the transaction for as an asset acquisition of in process research & development (IPR&D) with no alternative future use. The Company recognized the entire amount of the consideration of $153,400,000 as research and development expenses upon closing the transaction

Other expenses for the six months ended January 31, 2026, and 2025, represent primarily interest expenses of $146 and $3,762 to our related parties, on funds advanced to the Company, interest expenses of $97,670 and $0 in connection with note payable, other interest expenses of $0 and $146 and interest income of $1,740 and $81, respectively.

**Liquidity and Capital Resources**

***Balance Sheet Data:***

---

| | | |
|:---|:---|:---|
|  | **January 31, 2026** | **July 31, 2025** |
| Cash | $17061 | $85980 |
| Current Assets | 81255 | 95424 |
| Current Liabilities | 4255467 | 155355 |
| Working Capital (Deficiency) | $(4174212) | $(59931) |

---

As of January 31, 2026, our current assets were $81,255 and our current liabilities were $4,255,467 which resulted in working capital deficiency of $4,174,212. As of January 31, 2026, current assets were comprised of $17,061 in cash, $7,151 in prepaid expenses and $57,043 in accounts receivable compared to $85,980 in cash, $6,901 in prepaid expenses and $2.543 in accounts receivable as of July 31, 2025. As of January 31, 2026, current liabilities were comprised of $292,225 in accounts payable and accrued liabilities, $11,653 in short - term advance payable, $46,734 in operating lease liabilities and $3,904,855 in note payable -related party compared to $91,206 in accounts payable and accrued liabilities $11,653 in short-term advances payable, $7,111 in due to related parties and $45,385 in operating lease liabilities - current portion as of July 31, 2025.

As of January 31, 2026, our working capital (deficiency) increased by $4,114,281 from a $59,931 working capital deficiency at July 31, 2025, to $4,174,212 of working capital deficiency at January 31, 2026, primarily due to a decrease in current assets of $14,169 and an increase in current liabilities of $4,100,112.

***Cash Flow Data:***

---

| | | | |
|:---|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** | |
|  | **January 31,** | **January 31,** | |
|  | **2026** | **2025** | <br><br>**Changes** |
| Cash Flows used in Operating Activities | $(241308) | $(41287) | $(200021) |
| Cash Flows provided by Financing Activities | $172389 | $40000 | $132389 |
| Net Change in Cash During Period | $(68919) | $(1287) | $(67632) |

---

---

| |
|:---|
| 20 |
| *[**Table of Contents**](#toc)* |

---

***Cash Flows from Operating Activities***

We have not generated positive cash flows from operating activities. For the six months ended January 31, 2026, net cash flows used in operating activities were $241,308, consisting of a net loss of $153,790,175, reduced by research and development expenses -license of $153,400,000, imputed interest on related party's loan of $146, non-cash lease expenses of $20,812 and a net change in working capital of $127,909.

For the six months ended January 31, 2025, net cash flows used in operating activities were $41,287, consisting of a net loss of $191,076, reduced by imputed interest on related parties' loan of $3,762, stock - based compensation of $13,482, non-cash lease expenses of $19,539 and a net change in working capital of $113,006.

***Cash Flows from Investing Activities***

For the six months ended January 31, 2026, and 2025, no cashflows were provided by or used in investing activities.

***Cash Flows from Financing Activities***

We have financed our operations with loans from related parties and stock subscription.

For the six months ended January 31, 2026 and 2025, we received $0 and $0 from advances to pay certain operation expenses from related party loans, and repaid $7,111 and $10,000 to the related party, respectively.

During six months ended January 31, 2025, we received $50,000 from an investor for purchasing 100,000 shares of restricted common stock of the Company at a price of $0.50 per share.

During six months ended January 31, 2026, we received an aggregate amount of $535,000 from two investors for purchasing 101,074 shares of restricted common stock of the Company at a price of $3.50 -$5.49 per share.

During the six months ended January 31, 2026, we repaid partial note payable for amount of $355,500.

**Going Concern**

As of January 31, 2026, our company had a net loss of $153,790,175 and an accumulated deficit of $177,094,294. Our company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending July 31, 2026. The ability of our company to emerge from the development stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of our business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings. These conditions raise substantial doubt about our company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Critical Accounting Policies**

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management's application of accounting policies. We believe that understanding the basis and nature of the estimates and assumptions involved with the following aspects of our financial statements is critical to an understanding of our financial statements.

---

| |
|:---|
| 21 |
| *[**Table of Contents**](#toc)* |

---

**Off-Balance Sheet Arrangements**

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

As a "smaller reporting company," we are not required to provide the information required by this Item.

**Item 4. Controls and Procedures.**

***Evaluation of Disclosure Controls and Procedures***

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2026. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms as a result of the following material weaknesses:

The Company has no formal control process related to the identification and approval of related party transactions.

Segregation of Duties – As a result of limited resources, we did not maintain proper segregation of incompatible duties, namely the lack of an audit committee, an understaffed financial and accounting function, and the need for additional personnel to prepare and analyze financial information in a timely manner and to allow review and on-going monitoring and enhancement of our controls. The effect of the lack of segregation of duties potentially affects multiple processes and procedure

A "material weakness" is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements would not be prevented or detected on a timely basis.

We expect to be materially dependent upon a third party to provide us with accounting consulting services for the foreseeable future. Until such time as we have a chief financial officer with the requisite expertise in U.S. GAAP, there are no assurances that the material weaknesses in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements which could lead to a restatement of those financial statements.

***Changes in Internal Controls***

There have been no changes in our internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of Securities Exchange Act Rule 13a-15 or Rule 15d-15 that occurred in the six months ended January 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

---

| |
|:---|
| 22 |
| *[**Table of Contents**](#toc)* |

---

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings.**

From time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business. We are aware that Jeffrey Kilgore filed a lawsuit on August 28, 2025, in Jefferson County, Texas. *Cause No. 25DCCV1693, Jefferson County, Texas; Jeff Kilgore vs. Panamera Holdings Corporation;* the Plaintiff is claiming he is owed certain shares in compensation for services. This claim is disputed and without merit. Kilgore has requested a temporary injunction, and the hearing for same is set for January 22, 2026, then after it was postponed with new date to be set later. At this point an estimate for possible range of loss cannot be made. The company believes this is without merit, and we intend to vigorously defend against it. To the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party, and which would reasonably be likely to have a material adverse effect on our Company.

**Item 1A. Risk Factors.**

As a "smaller reporting company," we are not required to provide the information required by this Item.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

On August 1.2025, the Company issued 27,000,000 shares of restricted common stock in connection with the executed license acquisition (Financial Statements, Note 4).

On August 1, 2025, the Company entered into a Head License Agreement "Agreement" with an entity" Target" for acquisition license of Target's innovation systems for use along pursuing strategic partnership and merger of the Company and Target. The Company will have a license to Target's system technology for carbon conversion to fullerenes and nanotubes. The consideration license fees agreed (i) one - time up-front payment of $4,900,000, (ii) ongoing license fee of 25% of the net income generated from license's activities (iii) grant of 27,000,000 shares of restricted common stock of the Company. On August 1, 2025, the Company issued 27,000,000 shares of restricted common stock in connection with executed the license acquisition and it was valued at $148,500,00.

On September 4, 2025, the Company issued 91,074 shares of restricted common stock at prices of $5.49 per share for an amount of $500,000 in cash.

On September 9, 2025, the Company issued 50,000 shares of restricted common stock at prices of $2.00 per share to settle the stock subscription payable of $100,000.

On December 4, 2025, the Company issued 10,000 shares of restricted common stock at prices of $3.50 per share for an amount of $35,000 in cash.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not Applicable.

**Item 5. Other Information.**

None.

---

| |
|:---|
| 23 |
| *[**Table of Contents**](#toc)* |

---

**Item 6. Exhibits.**

The following exhibits are included as part of this report:

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description** |
| **(3)** | **Articles of Incorporation and Bylaws** |
| [3.1](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_3-1.htm) | [Articles of Incorporation (Incorporated by reference to our Registration Statement on Form S-1 filed on September 26, 2014)](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_3-1.htm) |
| [3.2](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_3-2.htm) | [Bylaws (Incorporated by reference to our Registration Statement on Form S-1 filed on September 26, 2014)](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_3-2.htm) |
| **(10)** | **Material Agreement** |
| [10.1](http://www.sec.gov/Archives/edgar/data/1620749/000164033425001381/pnht_ex991.htm) | [Head License Agreement with Rain Carbon, Inc. (Rain Cage) date August 1, 2025 for securing exclusive rights to the innovative systems of Rain Cage for use in the U.S and Mexico, including groundbreaking carbon conversion and clean energy technologies (Incorporated by reference to our Registration Statement on Form 8-K filed on August 7, 2025)](http://www.sec.gov/Archives/edgar/data/1620749/000164033425001381/pnht_ex991.htm) |
| **(14)** | **Code of Ethics** |
| [14.1](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_14-1.htm) | [Code of Ethics for Directors, Officers, and Employees (incorporated by reference to exhibit 14.1 in our Registration Statement on Form S-1 filed on September 26, 2014)](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_14-1.htm) |
| [14.2](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_14-2.htm) | [Code of Ethics for CEO And Senior Financial Officers (incorporated by reference to exhibit 14.2 in our Registration Statement on Form S-1 filed on September 26, 2014)](http://www.sec.gov/Archives/edgar/data/1620749/000155724014000539/ex_14-2.htm) |
| **(31)** | **Rule 13a-14 (d)/15d-14d) Certifications** |
| [31.1\*](pnht_ex311.htm) | [Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes - Oxley Act of 2002](pnht_ex311.htm) |
| [31.2\*](pnht_ex312.htm) | [Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes - Oxley Act of 2002](pnht_ex312.htm) |
| **(32)** | **Section 1350 Certifications** |
| [32.1\*](pnht_ex321.htm) | [Certification of Chief Executive Officer pursuant to Section 906 Certifications under Sarbanes - Oxley Act of 2002](pnht_ex321.htm) |
| [32.2\*](pnht_ex322.htm) | [Certification of Chief Financial Officer pursuant to Section 906 Certifications under Sarbanes - Oxley Act of 2002](pnht_ex322.htm) |
| 101\* | Inline XBRL Document Set for the condensed financial statements and accompanying notes in Part I, Item 1, "Financial Statements" of this Quarterly Report on Form 10-Q. |
| 104\* | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. |

---

___________

*\** *Filed herewith.*

*\*\** *Furnished herewith.*

---

| |
|:---|
| 24 |
| *[**Table of Contents**](#toc)* |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **PANAMERA HOLDINGS CORPORATION** | **PANAMERA HOLDINGS CORPORATION** |
|  | (Registrant) | (Registrant) |
| Dated: March 23, 2026 | By: | */s/ T. Benjamin Jennings* |
|  |  | T. Benjamin Jennings |
|  |  | President, Chief Executive Officer and Director |
|  |  | (Principal Executive Officer) |

---

---

| | | |
|:---|:---|:---|
| Dated: March 23, 2026 | By: | */s/ Douglas G. Baker* |
|  |  | Douglas G. Baker |
|  |  | Chief Financial Officer, Treasurer, Director |
|  |  | (Principal Financial/Accounting Officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT AND RULE 13a-14(a)**

**OR 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934**

I, T. Benjamin Jennings, certify that:

1. I have reviewed this report on Form 10-Q of Panamera Holdings Corporation for the quarter ended January 31, 2026;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: March 23, 2026 | By: | */s/ T. Benjamin Jennings* |
|  |  | T. Benjamin Jennings |
|  |  | President, Chief Executive Officer and Director |
|  |  | (Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION OF PRINCIPAL ACCOUNTING AND FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT AND RULE 13a-14(a)**

**OR 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934**

I, Douglas G. Baker, certify that:

1. I have reviewed this report on Form 10-Q of Panamera Holdings Corporation for the quarter ended January 31, 2026;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: March 23, 2026 | By: | */s/ Douglas G. Baker* |
|  |  | Douglas G. Baker |
|  |  | Chief Financial Officer, Treasurer, Director |
|  |  | (Principal Financial/Accounting Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER** 

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Panamera Holdings Corporation (the "Company"), for the quarter ended January 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, T. Benjamin Jennings, President, Chief Executive Officer and Director (Principal Executive Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

---

| | | |
|:---|:---|:---|
| Dated: March 23, 2026 | By: | */s/ T. Benjamin Jennings* |
|  |  | T. Benjamin Jennings |
|  |  | President, Chief Executive Officer and Director |
|  |  | (Principal Executive Officer) |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION PRINCIPAL ACCOUNTING AND FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Panamera Holdings Corporation (the "Company"), for the quarter ended January 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Douglas G. Baker, Chief Financial Officer and Director (Principal Financial Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

---

| | | |
|:---|:---|:---|
| Dated: March 23, 2026 | By: | */s/ Douglas G. Baker* |
|  |  | Douglas G. Baker |
|  |  | Chief Financial Officer, Treasurer, Director |
|  |  | (Principal Financial/Accounting Officer) |

---